A new side effect of popular GLP-1 weight loss medications is providing a boost to the plastic surgery industry, with facial plastic surgeons reporting a notable uptick in requests for fat-grafting procedures. The trend, often referred to as “Ozempic Face,” has seen a 50% rise in the number of patients seeking treatment for facial volume loss caused by rapid weight loss.
Dr. Patrick Byrne, President of the American Academy of Facial Plastic and Reconstructive Surgery, explains that while GLP-1 drugs like Ozempic are highly effective in achieving quick weight loss, they can result in undesirable effects such as sagging skin and reduced facial volume. “These drugs often result in issues like volume loss, which can lead to an aged or hollow appearance,” Dr. Byrne said.
Despite the surge in demand for facial enhancements linked to GLP-1 medications, procedures such as rhinoplasty, facelifts, and eyelid surgeries continue to dominate the list of most popular cosmetic surgeries. A recent survey by the Academy revealed that facelifts are seeing an increasing number of younger patients, signaling a shift in cosmetic surgery demographics.
On the non-surgical front, Botox and dermal fillers remain the most in-demand treatments, making up 80% of all cosmetic procedures. Additionally, there has been a marked increase in the number of men opting for these treatments, reflecting a broader trend toward male participation in the aesthetic industry.
Interestingly, hair transplantation is one area where men significantly outnumber women, maintaining its status as the only procedure with a gender disparity in patient demand.
Related topic:
Lisa Rinna Responds to Plastic Surgery Criticism by Reversing Procedures
Gogo Manzini Undergoes Multiple Cosmetic Surgeries for Self-Improvement
Nicole Kidman’s “Pixie Ears” Spark Facelift Rumors
